Basel Medical Group Ltd (BMGL) Form 6-K — Sep 2, 2026

Basel Medical Group Ltd (Nasdaq: BMGL), a Singapore-based healthcare company, disclosed board changes in a Form 6-K dated September 2, 2026. Current directors Fung Keng Leong (Raymond) and Tan Boon Chye (Darren) stepped down from the board with immediate effect, though Tan remains the company's chief commercial officer. Three new directors joined the board: Yang Xinwen, Cao Juan, and Frederick Hong Shieh Ming, who was appointed as an independent director. The filing notes that none of the new directors hold any beneficial ownership in the company's shares.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.